Pfizer (NYSE: PFE) is seeing some call buying this morning with the March $19 calls trading over 11,000 times so far. Large blocks of calls were bought on the offer; this action is below open interest, however, so it is unclear whether this is new positioning or closing transactions. Neither here nor there, this still gives a bullish tone to the stock.